2 months Amgen Gears Up to Report Q3 Earnings: Here’s What to Expect Zacks
Volume growth from AMGN’s key drugs like Prolia, Repatha and Evenity, among others, is expected to have been partially offset by biosimilar/generic competition for mature drugs.
X